The Latest Biotechnology / Pharmaceuticals Articles from Streetwise Reports


'Undervalued' Biopharma Features Robust Pipeline, Future Upside

Research Report
  ()
The case for investing in this company was made in an H.C. Wainwright & Co. report. read more >

California Gold Mining Full Speed Ahead in Hemp

Contributed Opinion
  ()
Peter Epstein of Epstein Research provides an update on a mining exploration company that is diversifying into the hemp market. read more >

Analyst: Biopharma, Now Stronger Than Ever, Is an Ideal Takeout Target

Research Report
  ()
An argument is made in a ROTH Capital Partners report for a potential imminent deal involving this drug maker. read more >

Developer of Cannabinoid-Based Drugs to Resume Cancer Pain Trial

Research Report
  ()
Calling this latest development "excellent news," Paradigm Capital has raised its target price on the company's stock. read more >

Immunotherapeutic Agent Shows Efficacy in Rare Respiratory Disease

Research Report
  ()
Trial results for this therapeutic, and their implications for this biotech, were discussed in an H.C. Wainwright & Co. report. read more >

Biopharma Expects Data Readouts in Psoriasis, NASH in H2/19

Research Report
  ()
Two recently launched clinical trials, and related conference calls, were reviewed in an H.C. Wainwright & Co. report. read more >
News Update

Innovative Healthcare Tech Firm to Acquire Two Vancouver Pharmacies

News Update
  ()
The transaction will allow the company to add a prescription fill and fulfillment component to its telemedicine app. read more >

Best-of-Breed Hemp/CBD Producers

Contributed Opinion
  ()
Fincom Investment Partners surveys the hemp-CBD landscape and discusses two companies it believes are "best of breed." read more >
News Update

Biopharma Hits Milestone in Starting Enrollment for NASH Clinical Trial

News Update
  ()
The company will discuss the trial when it hosts a conference call about this specific disease indication in April. read more >

Biopharma's Early Data Show Immunotherapy's Efficacy in Ovarian Cancer

Research Report
  ()
The "encouraging" data for this drug candidate as a monotherapy is the focus of an H.C. Wainwright & Co. report. read more >

California Gold Entering High-CBD Content Hemp Seed Market in the U.S.

Contributed Opinion
  ()
Peter Epstein of Epstein Research profiles a gold company that plans to grow hemp seed on its land. read more >

Premier Health Group Adding Medical Cannabis Support Tool

  ()
This clinical decision support software integration is the first of its kind, according to the company. read more >

San Diego Biopharma Features 'Strong and Balanced Pipeline'

Research Report
  ()
An H.C. Wainwright & Co. report discussed what sets this company's asset apart from similar products. read more >
News Update

Dosing Begins for California Biopharma's Proof-of-Concept Trial in Plaque Psoriasis

News Update
  ()
This U.S. study follows encouraging results from a Phase 1b trial in the same indication in Australia. read more >
News Update

Biotech Stresses Need to Target Only Toxic Oligomer in Alzheimer's Therapies

News Update
  ()
The company cites the recent discontinuation of other firms' clinical programs as proof. read more >

Now Cashed Up, Biopharma to Advance Cholesterol-Lowering Therapy

Research Report
  ()
A ROTH Capital Partners report reviewed this New Jersey firm's plans for its lead asset. read more >

Several Data Catalysts Expected in 2019 for 'Underappreciated Story'

Research Report
  ()
An H.C. Wainwright & Co. report discussed what those are and why they could impact the biotech's valuation. read more >

Rare Diseases Biotech Provides Opportunity

Research Report
  ()
A ROTH Capital Partners report discussed why the stock price is at its current level and noted upcoming catalysts for the company. read more >
News Update

Tech Firm to Offer Solution to Inefficient, Expensive Health Clinic Business Model

News Update
  ()
The company will roll out virtual, remote medical services to change how primary care practices are run. read more >

Biopharma Expected to Bring 'Two First-in-Class Antibiotics to Market in 2019'

Research Report
  ()
The likely timelines for approval and commercialization of each drug are discussed in an H.C. Wainwright report. read more >
News Update

Antibody Therapeutics Developer to Present at March Alzheimer's/Parkinson's Conference

News Update
  ()
The biotech was selected to discuss its antibodies that selectively target toxic forms of alpha-synuclein. read more >

Health Tech Firm Completes Enrollment for Female Sexual Function Trial

Research Report
  ()
A Ladenburg Thalmann report reviewed the study design and purpose. read more >

Analyst: Biotech to Have 'Eventful Year' with Data Readouts in Three Indications

Research Report
  ()
This California company expects results from clinical trials in liver disease and psoriasis in 2019. read more >

Large US Market Now Open to Livestock Feed Antibiotic Replacement

  ()
Proprietary OxC-beta livestock feed supplement can supplant the need for maintenance antibiotics. read more >

Coverage Initiated on Cancer Vaccine Firm

Research Report
  ()
An H.C. Wainwright & Co. report explained the reasons for its "bullish view" on this California-based life sciences company. read more >
Showing Results: 1 to 25 of 74 Next

Get Our Streetwise Reports Resources Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"LIO announced aggressive plans to explore its consolidated property."
– Derek Macpherson, Red Cloud Klondike Strike Inc.
"Adding some possible blue sky to the GSV story is drilling at Lewis."
– Brien Lundin, Gold Newsletter (Jefferson Financial)
"AVU's Sesmarias could be an extension of the ore body at Lousal."
– Siddharth Rajeev, Fundamental Research Corp.
"Share price underperformance created a buying opportunity in SEA."
– Derek Macpherson, Red Cloud Klondike Strike Inc.